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Abstract
Background: Maternal smoking leads to intrauterine undernutrition and is associated with low birthweight and higher risk
of offspring obesity. Intrauterine smoke exposure (SE) may alter neuroendocrine mediators regulating energy homeostasis
as chemicals in cigarette smoke can reach the fetus. Maternal high-fat diet (HFD) consumption causes fetal overnutrition;
however, combined effects of HFD and SE are unknown. Thus we investigated the impact of combined maternal HFD and
SE on adiposity and energy metabolism in offspring.
Method: Female Balb/c mice had SE (2 cigarettes/day, 5 days/week) or were sham exposed for 5 weeks before mating. Half
of each group was fed HFD (33% fat) versus chow as control. The same treatment continued throughout gestation and
lactation. Female offspring were fed chow after weaning and sacrificed at 12 weeks.
Results: Birthweights were similar across maternal groups. Faster growth was evident in pups from SE and/or HFD dams
before weaning. At 12 weeks, offspring from HFD-fed dams were significantly heavier than those from chow-fed dams
(chow-sham 17.660.3 g; chow-SE 17.860.2 g; HFD-sham 18.760.3 g; HFD-SE 18.860.4 g, P,0.05 maternal diet effect); fat
mass was significantly greater in offspring from chow+SE, HFD+SE and HFD+sham dams. Both maternal HFD and SE affected
brain lactate transport. Glucose intolerance and impaired brain response to insulin were observed in SE offspring, and this
was aggravated by maternal HFD consumption.
Conclusion: While maternal HFD led to increased body weight in offspring, maternal SE independently programmed
adverse health outcomes in offspring. A smoke free environment and healthy diet during pregnancy is desirable to optimize
offspring health.
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Introduction
Childhood obesity is currently a major health problem within
the global obesity pandemic, with 22 million children under five
estimated as overweight/obese [1]. In the long term, 50% of obese
adolescents will remain obese in adulthood [2], increasing their
risk of developing associated insulin resistance and cardiovascular
disease, adding to the already enormous cost of obesity related
diseases. Unhealthy maternal nutrition during gestation, including
both under- and over-nutrition, is critical in predisposing the
offspring to obesity and related disorders during postnatal
development [3,4].
While maternal obesity represents a common threat to the
wellbeing of the next generation, intrauterine undernutrition is not
uncommon. In western countries, maternal smoking during
pregnancy is a major cause of intrauterine undernutrition, leading
to low body weight [5,6] and head circumference [6,7] at birth. A
number of studies have revealed a strong inverse relationship
between birthweight and the risk of developing abdominal obesity,
hypertension, and metabolic disorders from childhood [8,9,10,11].
About 20–50% of women report smoking at the onset of
pregnancy [12], with 25–29% of women arriving at the end of
their pregnancy without stopping smoking, and 50% of non-
smoking mothers were exposed to passive smoking during
pregnancy [13].
There are several theories underlying the problem of lower birth
weight. Firstly, vascular changes due to nicotine and carbon
monoxide in the mothers could limit nutrient delivery to the fetus
to restrict intrauterine growth. Secondly, catecholamines released
from the adrenal glands and nerve cells due to smoke exposure
(SE) can cause vasoconstriction to limit placental blood flow,
restricting intrauterine nutrition [14]. In response to undernutri-
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by reducing supply to other less vital organs. These adaptations
limit cell numbers in key organs, such as liver and muscle, altering
glucose and fat metabolism [15], increasing the prevalence of type
2 diabetes [15]. Indeed, maternal smoking is associated with
increased risk of both childhood and adulthood obesity in offspring
[16,17,18,19,20,21].
However, the impact of maternal smoking on offspring is likely
more than just intrauterine undernutrition caused by placental
limitation. We previously showed that both short- and long-term
smoke exposure (SE) leads to reduced energy intake and weight
gain in normal mice [22,23,24]. Many energy homeostatic
regulators, such as the appetite-stimulant neuropeptide Y (NPY),
the anorexigenic hormone leptin, and uncoupling proteins, were
found to be changed by SE [23]. The addictive substance of
cigarette smoke, nicotine, can accumulate in the fetus, which was
shown to change the chemicals involved in its energy homeostasis
[25], leading to low birth weight. Products of cigarette smoke, such
as carbon monoxide, can also directly affect the fetal brain and
organs [14], which may have a major impact on fetal
development, in addition to that of nicotine. Therefore, the means
by which maternal smoking affects the energy metabolism in
offspring remains unclear.
Both active and passive smoking have been reported to
contribute to glucose intolerance and insulin resistance, leading
to type 2 diabetes [26,27]. Increased glucose intolerance was also
reported in offspring of smoking mothers. However, it is unknown
whether this is a direct outcome of maternal smoking during
pregnancy or secondary to their own unhealthy eating habits and
lifestyle, as offspring from smoking parents are more likely to
consume a poor diet and be inactive [5,28,29,30]. Nevertheless,
maternal smoking can lead to obesity and related disorders, such
as insulin resistance and glucose intolerance, in both childhood
and adulthood [4,8,9,10,11,31,32]. Insulin receptors are widely
distributed in the brain and concentrated in the appetite regulating
centre, the hypothalamus [33], exerting both central and
peripheral effects. Brain insulin infusion can reduce food intake
and body weight in a dose-dependent manner, while injection of
insulin antibodies exerts opposite effects [34,35]. This is because
insulin and the anorexic hormone leptin share common
intracellular signaling pathways via insulin receptor substrate
and the enzyme phosphoinositide 3-kinase [36], enabling cross talk
effects on feeding regulation. More interestingly, brain insulin
signaling is required to inhibit glucose synthesis in the liver [37],
and glucose metabolism within the brain can also regulate blood
lipid levels and subsequent insulin sensitivity [38]. This suggests
that any dysfunction of brain insulin action due to altered signaling
pathway or brain glucose metabolic orders can contribute to
hyperglycemia and subsequent glucose intolerance, one of the first
manifestations towards the development of Type 2 diabetes.
However, none of the previous studies has drawn a connection
between maternal smoking and programming of abnormal brain
insulin response that leads to obesity and glucose intolerance
phenotype in offspring.
On the other hand, maternal high-fat diet (HFD) consumption
is known to cause intrauterine overnutrition, which has been
shown to program glucose intolerance in offspring even when they
consumed low fat diet [32]. Surprisingly, infant growth retardation
was reported in some obese mothers smoking during pregnancy
[39]. This suggests that HFD consumption cannot always reverse
the intrauterine undernutrition due to maternal smoking.
However, to date no work has systematically studied the effects
of maternal cigarette SE in combination with HFD consumption
on the adiposity and metabolic changes in offspring. We
postulated that when obesity and smoking coincide during
pregnancy, they may have additive deleterious effects on fetal
energy homeostasis.
It has been reported that maternal smoking has no impact on
the body weight of female offspring [18]. However, the metabolic
changes in the female offspring remain largely unknown, thus in
this study female offspring were examined. We hypothesized that
long-term maternal SE prior to and during gestation would alter
hypothalamic appetite regulators, especially their response to
insulin challenge, to promote hyperphagia and adiposity in female
offspring. We also hypothesized that maternal HFD feeding would
exaggerate the detrimental impact of maternal SE on offspring. By
feeding the offspring with balanced low fat diet, the intrauterine
impact on adiposity and glucose metabolism can be distinguished
from that from unhealthy dietary habit.
Materials and Methods
1. Ethics Statement
This study was approved by the Animal Care and Ethics
Committee of the University of New South Wales (ACEC #06/
61B).
2. Animals
Female Balb/c mice (n=36, 7 weeks, Animal Resources
Centre, Perth, Australia) were housed at 2062uC, and maintained
on a 12:12 h light/dark cycle (lights on 06:00 h). One group of
mice were fed standard laboratory chow (11 kJ/g, 14% fat, 21%
protein, 65% carbohydrate, Gordon’s Specialty Stockfeeds, NSW,
Australia), while the second group was fed a palatable cafeteria
style HFD providing 15.33 kJ/g (34% fat, 19% protein, 47%
carbohydrate) as described previously [32,40]. Within each dietary
cohort, half the mice were exposed to cigarette smoke (SE, 2
cigarettes/day, 5 days/week, nicotine#1.2 mg, CO#15 mg,
Philip Morris, VIC, Australia) inside a perspex chamber for
30 min. The control sham exposed mice were put in an identical
chamber for the same period. This yielded 4 maternal groups,
chow+sham, chow+SE, HFD+sham, and HFD+SE. The offspring
from these 4 maternal groups were named chow-sham, chow-SE,
HFD-sham, and HFD-SE, respectively.
Dietary and SE interventions continued for 5 weeks before
females were mated with male mice (9 weeks) from the same
source. The same treatment continued throughout gestation and
lactation. During lactation the offspring remained in the home
cage without SE. Pups were weighed every 4 days and weaned at
postnatal day 20. Female breeders were killed by anesthetic
overdose (ketamine/xylazine 180/32 mg/kg, i.p.) 1 day after pups
were weaned. All female offspring were fed chow after weaning
and sacrificed at 12 weeks. Energy intake and body weight were
recorded weekly after weaning.
3. Offspring IP glucose tolerance test (IPGTT)
At 11 weeks of age, an IPGTT was performed. Animals were
fasted for 5 h and weighed. A blood sample was collected from the
tail tip to establish baseline glucose level at T0 by glucose meter
(Accu-ChekH, Roche Diagnostics, Nutley, USA). Mice were then
administered 2 g glucose/kg body weight (i.p.). Blood glucose
levels were measured at 15, 30, 60, and 90 min and expressed as
glucose level above baseline (T0). Area under the curve (AUC) was
calculated for each mouse.
4. Endpoint insulin injection and sample collection
At 12 weeks, 5 h-fasted female offspring were deeply anesthe-
tized (ketamine/xylazine 75/10 mg/kg, i.p.). Within each group,
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Actrapid, short-acting human insulin, Novo-Nordisc Pharmaceu-
ticals Pty. Ltd, Bagsvrd, Denmark) while the other half received
saline control. Offspring were culled 10 min post-injection.
After measurement of naso-anal (N-A) length, blood was
collected, plasma separated immediately and stored at 220uC
for leptin and insulin measurements. Then animals were killed by
decapitation. The whole hypothalamus was dissected, snap frozen
in liquid nitrogen, and stored at 280uC for measuring mRNA
expression of genes of interest. Body fat (gonadal, retroperitoneal
(Rp), and mesenteric) was dissected and weighed, as well as organs
(heart, liver, and kidney) and skeletal muscle (soleus, extensor
digitorum longus (EDL), and tibialis). Rp fat and liver were kept to
provide markers of metabolism. Tibia length was measured as a
marker of growth.
5. Leptin and insulin assays
Plasma leptin and insulin were measured using radioimmuno-
assay kits (Linco, St. Charles, Missouri, USA) with detection limits
of 0.5 and 0.05 ng/ml respectively. Intra- and inter- leptin assay
coefficients of variation of were 3.3% and 4.1% respectively. Intra-
and inter- insulin assay coefficient of variation were 2.2% and
8.9%, respectively.
6. Western blotting
Proteins were isolated from liver as previously described [31].
Protein concentration was determined by Bradford protein assay
(Bio-Rad Inc, Hercules, CA, USA) using BSA as standard.
Proteins (50 mg) were then separated on a polyacrylamide gel and
transferred to polyvinylidine fluoride membrane. Membranes
were incubated overnight at 4uC with the primary antibody for
target and housekeeping proteins (phosphorylated-protein kinase B
(PKB) Ser473, phosphorylated-glycogen synthase kinase-3b (GSK-
3b), Cell Signaling, Beverly, MA, USA; housekeeping b-actin,
Sigma, St. Louis, MO, USA), followed by secondary antibody
(Anti-rabbit IgG, HRP-linked Antibody, Cell Signaling, Beverly,
MA, USA) for 2 h. Protein expression was detected on medical X-
Ray film (SuperRX, Fujifilm Corporation, Tokyo, Japan),
developed and fixed using an automatic lightweight film processor
(CP1000, AGFA HealthCare NV B-2640 Mortsel, Belgium).
Protein band density was determined by scanning (ChemiDoc
XRS Bio-Rad Inc, Hercules, CA, USA) and quantified using Bio-
Rad Laboratories Quantity One 1-D Analysis Software. Results
are expressed in arbitrary units.
7. Quantitative real-time PCR
Total RNA was isolated from individual hypothalamus using
TriZol reagent (Invitrogen Australia Pty Limited, Melbourne,
VIC, Australia) according to manufacturer’s instructions. Purified
total RNA was used as a template to generate first-strand cDNA
using M-MLV Reverse Transcriptase, RNase H-, Point Mutant
Kit (Promega, Madison, WI, USA). Pre-optimized probe/primers
(Applied Biosystem, Foster City, CA, USA) were used for real-time
PCR (Realplex2, Eppendorf AG, Hamburg, Germany). Probe
sequences from 59R39 offered by manufactory and NCBI Gene
References are, adipose triglyceride lipase (ATGL): GCCTGC-
CTGGGTGAAGCAGGTGCCA (NM_025802.2), Carnitine pal-
mitoyl-transferase (CPT)-1a: ACCGTGAGCAGGTACCTG-
GAGTCTG (NM_013495.2), leptin: ACACACGCAGTCGG-
TATCCGCCAAG (NM_008493.3), monocarboxylate transporter
(MCT) 2: CCAGCTCCTTCACCAGCTCCCTAAG (NM_009197.
2), MCT4: CCACCAATAGCAGGCTGGATATATG (NM_
146136.1), NPY: ATCTCATCACCAGACAGAGATATGG
(NM_023456.2), proopiomelanocortin (POMC): AACCTGCT-
GGCTTGCATCCGGGCTT (NM_008895.3), single-minded
gene (Sim)1: TCTTTCCAGAAGGGCTTGGCGAGGC (NM_
011376.3), TNFa: CCCTCACACTCAGATCATCTTCTCA
(NM_013693.2), Y1 receptor: ATATTCATATGCTACTTCA-
AGATAT (NM_010934.3).
The target gene probes were labeled with FAM and
housekeeping gene 18s rRNA was labeled with VIC. Genes of
interest were quantified in a single multiplexing reaction, and
standardized to housekeeping genes. An individual sample from
the control group was assigned as calibrator against which all other
samples were expressed as fold difference. The results were further
confirmed by housekeeping gene GAPDH labeled by VIC.
8. Statistical methods
Results are expressed as mean6SEM. Data were tested for
normality (Graphpad Prism 5, La Jolla, CA, USA). Parameters not
normally distributed (N-A length, mesenteric fat mass, plasma
leptin and insulin concentrations, UCP1, and leptin mRNA
expression) were log transformed to normal distribution and then
analyzed. Body weight of pups over time was analyzed using
ANOVA with repeated measures, followed by post hoc Fisher’s
Least Significance Difference (LSD) test. Differences in fat and
organ weights, blood and plasma hormone concentrations, mRNA
and protein expression in all tissues were analyzed using two-way
ANOVA followed by a post hoc LSD test. P,0.05 was considered
significant.
Results
1. Effects of interventions on the breeders
The four groups of female breeders started at similar body
weights (Table 1). Mice fed a HFD consumed 33% and 45% more
calories in sham and SE groups, respectively (P,0.05, HFD
effect). After 5 weeks of intervention, those fed HFD were
significantly heavier than chow-fed females (P,0.05, HFD+sham
vs. chow+sham, HFD+SE vs. chow+SE), while SE mice were
significantly lighter than sham-exposed mice (P,0.05, chow+SE
vs. chow+sham, HFD+SE vs. HFD+sham; Table 1). At the
conclusion of the experiment, HFD-fed mice also had greater
adiposity in all locations sampled, whereas SE only significantly
reduced the ovarian fat mass in chow-fed mice (P,0.05, chow+SE
vs. chow+sham; Table 1). HFD consumption only significantly
increased liver weight, while SE markedly reduced both liver and
kidney weights (P,0.05, SE effect). Blood glucose level was only
reduced in chow+SE compared with chow+sham dams (P,0.05,
Table 1).
2. Effects of maternal intervention on offspring
2.1 Growth and adiposity. Although pups born of SE dams
(chow-SE and HFD-SE) appeared smaller than those from sham-
exposed dams, this did not reach statistical significance (Table 2).
However, after birth mice from dams exposed to either HFD or
cigarette smoke grew faster than those from the control dams
(chow-sham, Figure 1A). As a result, at weaning, pups in chow-SE,
HFD-sham and HFD-SE groups were 15%, 36% and 26%
heavier than the chow-sham group, respectively, despite all groups
consuming standard rodent chow. From 9 weeks, offspring from
HFD-fed mothers (HFD-sham & HFD-SE groups) became
significantly heavier than those from chow-fed mothers (P,0.05,
maternal HFD effect, Figure 1B). At 12 weeks, average body
weight of chow-sham mice was 7–10% smaller than the other 3
groups, and fat mass (Rp, gonadal, and mesenteric pads) was also
significantly smaller in chow-sham mice compared with the other
3 groups (P,0.05, Table 2). After standardizing by body weight,
Maternal Smoking and Obesity on Offspring
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27260only gonadal fat remained significantly different. Organ weights,
including liver, kidney and heart, showed a similar pattern as fat
mass, with chow-sham offspring having the smallest organ masses
(P,0.05, chow-sham vs. the other 3 groups, Table 2). Skeletal
muscle mass (soleus and EDL) were significantly greater in mice
from HFD-fed dams (P,0.05, maternal HFD effect, Table 2).
However, all these differences in organ and muscle mass
disappeared when data were standardized by body weight,
suggesting that the increase was proportional to body weight.
The body length reflected by N-A and tibia length was not
significantly different between groups. Interestingly, the daily
energy intake in the chow-sham group started to increase
markedly from 9 weeks (Figure 1C), and over the whole post-
weaning period it was greater than the other 3 groups, which were
at a similar level (P,0.05, chow-sham vs. all other groups, Table 2).
Concentrations of the adipose hormone leptin were only
significantly altered in chow-SE mice, which were 50% higher
than chow-sham mice (P,0.05, Figure 2A). This coincided with
significantly upregulated Rp leptin mRNA expression (P,0.05,
Figure 2B).
Table 1. Parameter of the female breeders.
Breeders chow+sham chow+SE HFD+sham HFD+SE
n=11 n=11 n=11 n=11
BW pre-treatment (g) 18.860.2 18.760.4 17.660.3 17.960.3
BW pre-pregnancy (g) 20.560.2 19.060.2
# 23.360.4* 21.260.4
#*
Energy intake (kJ/24 h) 38.061.5 36.361.5 50.864.1* 52.864.9*
Rp fat (mg) 30.2614.2 16.665.4 196.6627.8* 200.7652.1*
Gonadal fat (mg) 240.0687.3 122.6628.0
# 1026.26158.4* 993.56248.4*
Mesenteric fat (mg) 452.8625.4 368.9633.5 599.4636.9* 618.9668.6*
Liver (mg) 1484.5655.0 1066.1653.7
# 1640.56174.8* 1292.5646.5
#*
Kidney (mg) 154.563.8 138.164.32
# 145.964.6 141.063.7
Blood glucose (mmol/l) 9.2560.52 6.1160.41
# 9.5360.80 8.1361.00
#,P ,0.05, SE effect;
*, P,0.05, HFD effect. Results are expressed as mean 6 SE. Data were analysed by two-way ANOVA, followed by post hoc LSD tests.
BW: body weight; Rp: retroperitoneal.
doi:10.1371/journal.pone.0027260.t001
Table 2. Parameters of the female offspring.
Offspring chow-sham chow-SE HFD-sham HFD-SE
n=24 n=21 n=17 n=15
BW at 1 day (g) 1.4560.12 1.3560.06 1.4860.15 1.3860.07
BW at 20 days (g) 6.4960.14
Y 7.8360.2 9.2760.3 8.6260.29
BW at 12 weeks (g) 16.360.2
Y 17.460.2 17.960.3 17.460.5
Energy intake (kJ/24 h) 40.264.5
Y 35.363.7 34.364.2 33.763.3
N-A length (cm) 8.5760.15 8.9260.05 8.7660.07 8.8460.06
Tibia length (cm) 1.9360.02 1.9060.02 1.9760.01 1.9660.01
Mesenteric fat (mg) 336.667.6
Y 376.1610.3 404.8636.9 378.7616.8
Gonadal fat (mg) 295.067.66
Y 384.9622.0 404.8636.9 373.7627.7
Rp fat (mg) 72.263.4
Y 85.963.6 103.565.8 96.166.9
Liver (mg) 646.6613.2
Y 673.6612.2 718.9617.7 693.9618.8
Kidney (mg) 92.061.7
Y 98.661.9 99.862.1 98.062.7
Heart (mg) 84.562.0
Y 91.161.7 94.061.7 90.961.4
EDL (mg) 13.160.30 13.360.4 14.260.4* 14.460.6*
Soleus (mg) 9.1560.19 10.160.21
# 11.160.50* 9.9360.32
#
Tibialis (mg) 64.460.8 67.863.0 69.161.8 66.861.9
Plasma insulin (ng/ml) { 0.0760.02 0.0960.02 0.0460.01 0.0760.03
Results are expressed as mean 6 SEM ({ n=6–10). Data were analysed by two-way ANOVA, followed by post hoc LSD tests.
YP,0.05, different from the other 3 groups;
*P,0.05, maternal HFD effect;
#P,0.05, maternal SE effect.
BW: body weight; EDL: extensor digitorum longus; N-A: naso-anus; Rp: retroperitoneal.
doi:10.1371/journal.pone.0027260.t002
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IPGTT) was lower in offspring of HFD+SE dams (4.3560.25 mM
vs. 6.1760.16 mM in HFD-sham group, P,0.05, maternal SE
effect), it was similar between chow-sham (6.6760.31 mM) and
chow-SE (5.9360.13 mM) groups. When standardized by basal
levels, at 15 and 30 min post-glucose injection, mice from SE
dams had significantly greater increments in glucose (chow-SE
+8.1360.94 mM, HFD-SE +8.8060.51 mM) than those from
sham-exposed dams (chow-sham +4.4060.48 mM, HFD-sham
+5.2860.66 mM, P,0.05, maternal SE effect, Figure 3A); glucose
levels in HFD-SE mice remained significantly higher than chow-
SE group until 60 min post-injection (P,0.05, maternal HFD
effect). These differences were also reflected in the AUC (P,0.05,
maternal SE & HFD effects, Figure 3B). At 90 min post-injection,
the blood glucose levels in chow-sham, chow-SE, and HFD-sham
groups had returned to baseline, but not in the HFD-SE group.
At 12 weeks, plasma insulin concentration was not significantly
different between groups (P,0.05, Table 2). Rp TNFa mRNA
expression was significantly increased in the chow-SE, HFD-sham
and HFD-SE groups compared with chow-sham group (P,0.05,
Figure 3C). In liver, upon exogenous insulin stimulation,
phosphorylated-PKB levels tended to be decreased in the HFD-
SE group, as reflected in a decreased ratio of phosphorylated/total
PKB although not reaching statistical significance (Figure 3D).
2.3 Energy homeostasis regulators in the
hypothalamus. Maternal obesity regulated hypothalamic
NPY mRNA, which was lower in offspring from HFD+sham
and HFD+SE dams (P,0.05 maternal HFD effect, Figure 4A),
and Y1 receptor mRNA was reduced in offspring from the
maternal groups with interventions (chow-SE, HFD-sham, HFD-
SE pups, Figure 4B), in line with their lower average energy intake
over the whole postweaning period shown in Table 2.
Hypothalamic POMC mRNA expression was not different
among the 4 groups (Figure 4C), while amongst the SE
offspring, Sim1 mRNA was significantly reduced by HFD
(chow-SE vs. HFD-SE groups; Figure 4D).
Phosphorylated (P) PKB and P/total GSK-3b, were similar
between groups (Figure 4E,F). Ten minutes after a peripheral
injection of insulin, these proteins were not significantly increased
(Figure 4E,F). However, hypothalamic NPY mRNA expression in
the chow-sham and HFD-sham groups was significantly reduced
(P,0.05, insulin effect, Figure 4A), but this was not observed in the
offspring from SE dams. POMC mRNA expression was not
significantly changed after insulin injection (Figure 4C).
Hypothalamic MCT2 mRNA was downregulated in offspring
from HFD-fed dams (P,0.05, maternal HFD effect, Figure 5A),
while MCT4 was reduced in both HFD-fed and SE groups
(P,0.05, maternal HFD and SE effects, Figure 5B).
Figure 1. Body weight changes of the offspring mice. Body weight changes during the suckling and post-weaning periods in chow-sham
(open square n=24), chow-SE (solid square n=21), HFD-sham (open circle n=17), and HFD-SE (solid circle n=15) groups. Results are expressed as
mean 6 SEM. Data were analysed by ANOVA with repeated measures followed by a post hoc LSD test. *, P,0.05, maternal HFD effect. Y, P,0.05,
chow-sham significantly different from the other 3 groups. Chow-sham: offspring from dam fed chow & sham exposed; chow-SE: offspring from dam
fed chow & cigarette smoke exposed; HFD-sham: offspring from dam fed HFD & sham exposed; HFD-SE: offspring from dams fed HFD & cigarette
smoke exposed.
doi:10.1371/journal.pone.0027260.g001
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expression was significantly increased in the HFD-sham group
compared with all other groups when standardized to 18s
(P,0.05, Figure 6A), Rp ATGL mRNA expression was
upregulated in the chow-SE and HFD-sham groups (P,0.05
compared with chow-sham mice, Figure 6B), but such adaptation
disappeared when maternal HFD consumption and SE were
combined. Similar relative changes were observed in mRNA
expression when GAPDH was used as housekeeping gene,
although the magnitude of the increase in CPT-1a was lower
(data not shown).
Discussion
The current study investigated two factors that may coexist
during gestation in western society, cigarette SE and HFD-
consumption. It revealed that maternal SE alone only led to faster
weight gain during the suckling period while maternal HFD-
consumption led to greater body weight gain throughout the
lifespan of the offspring, from the suckling period to adulthood.
However, maternal SE appeared to be an independent factor to
determine glucose intolerance and some abnormal brain responses
to insulin in offspring. The addition of maternal HFD consump-
tion exaggerated the degree of glucose intolerance in offspring,
enhancing the risk of them developing metabolic disorders.
Maternal nutrition during gestation can directly impact the
wellbeing of the offspring in both childhood and adulthood.
Smoking is an addictive behaviour with low cessation rate, and
repeated relapse on cessation is common [41]. Difficulty
controlling weight gain upon smoking cessation is another reason
preventing people from quitting [42,43]. As a result, a significant
number of women do not stop smoking even during pregnancy.
This markedly compromises the health of the offspring as shown in
the current study and by others [17,20,21,44,45,46,47,48,49].
Low birthweight is commonly associated with maternal smoking
[7,25,50], and we observed this trend in pups from SE dams,
without statistical significance. This may be related to the relatively
low cigarette dose employed in the current study, which may also
contribute to the unaltered daily energy intake of the dams,
especially in HFD-fed mice [40]. We did observe smaller body
weight in both chow+SE and HFD+SE breeders, suggesting that
SE can affect body weight without any impact on food intake, as
observed in humans [51]. The lower maternal body weight could
be due to increased energy expenditure observed in our previous
studies [22,23,24], which may have affected fetal growth. It also
has to be considered that smoking per se is a predisposing factor for
abdominal obesity when dietary fat is not restricted [52], as shown
by our previous study [53] and in the dams here. In HFD+SE
dams, the Rp and mesenteric fat masses were unchanged
compared with HFD+sham dams, suggesting that loss of lean
body mass contributed to the smaller body weights. Smoking is
strongly associated with wasting [54] due to increased protein
turnover [55]. While muscle loss is one of the major contributors
[54], reduced mass of other organs may also play a role, such as
the lower kidney and liver weights in SE dams observed in this
study. SE in the HFD-fed dams reduced the liver weight gain,
associated with lipid accumulation due to HFD [56]. With
increased adiposity in the dams, the fetuses would suffer from the
detrimental impact from both maternal SE and obesity; both of
these factors alone are known to cause various metabolic disorders
in offspring.
Following intrauterine growth retardation linked to SE, faster
postnatal growth is commonly observed in children, leading to
childhood obesity [5,28,57]. In the current study, significantly
faster growth was displayed in offspring with maternal SE and/or
obesity, suggesting that any negative intrauterine environment has
the capacity to disturb normal postnatal development. As a result,
all of these offspring had significantly greater adiposity. Adipose
CPT-1a and ATGL mRNA expression were increased in chow-
SE and/or HFD-sham groups respectively, suggesting enhanced
fatty acid oxidation and lipolysis. This could be an adaptation in
response to the faster growth, but not sufficient to reverse the
increased adiposity. However, such adaptation disappeared in the
HFD-SE group, demonstrating an enhanced metabolic risk when
maternal obesity and SE were combined.
Both active and passive smoking contribute to glucose
intolerance and insulin resistance, leading to type 2 diabetes
[26,27]. The fact that glucose intolerance was displayed in mice
from SE dams regardless of maternal diet, suggests that maternal
smoking has a very strong influence on the glucose metabolism of
offspring. With fetal nicotine concentrations generally being 15%
above maternal levels [58], it is very likely that cigarette smoke
Figure 2. Plasma level and fat mRNA expression of leptin.
Plasma leptin (n=15–24) and leptin mRNA expression in Rp fat (n=10–
12). Results are expressed as mean 6 SEM. Data were analysed by two-
way ANOVA followed by a post hoc LSD test. #, P,0.05, significantly
different from chow-sham group. Chow-sham: offspring from dam fed
chow & sham exposed; chow-SE: offspring from dam fed chow &
cigarette smoke exposed; HFD-sham: offspring from dam fed HFD &
sham exposed; HFD-SE: offspring from dams fed HFD & cigarette smoke
exposed.
doi:10.1371/journal.pone.0027260.g002
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involved in glucose disposal and insulin sensitivity, explaining the
glucose intolerance observed in the offspring of SE dams. Recent
studies also showed an increased pancreatic beta-cell apoptosis and
changes in gene expression following fetal and neonatal exposure
to nicotine [46,49]. It has been speculated that the impaired
insulin sensitivity among smokers may be due to nicotine, carbon
monoxide, or other agents in tobacco smoke [59]. In addition,
visceral obesity caused by smoking is also thought to be a key
contributor even in children [60]. TNFa is one of the
inflammatory cytokines directly causing hepatic insulin resistance.
All these contributing factors found in humans were present in the
offspring from SE dams in the current study, possibly leading to
their impaired insulin action. Lower baseline insulin concentration
at 12 weeks in the HFD-sham group is different from our previous
findings in the rat [32]. It has been shown that maternal HFD
consumption impairs b-islet function in offspring [61], which may
lead to low baseline insulin concentration at some stage of
development. Low insulin release may directly lead to delayed
glucose clearance during IPGTT in offspring from HFD+SE dams
compared with those from chow+SE dams.
In the current study, impairment in the response to insulin was
evident in the hypothalamus. Interestingly, insulin receptors and
signaling pathways are present in the hypothalamus, specifically in
the arcuate nucleus, where NPY and POMC are predominantly
synthesized [62,63], and in mice fed HFD the defect in
hypothalamic insulin action precedes liver insulin resistance [64].
Central insulin signaling has been shown to reduce NPY and
increase POMC expression in the hypothalamus [65]. Although
the phosphorylation of PKB and GSK3b protein were not
Figure 3. Glucose tolerance and markers related to insulin sensitivity. (A) Change in blood glucose levels above the baseline values during
an IPGTT at 11 weeks (glucose 2 g/kg, n=6) in chow-sham (open square), chow-SE (solid square), HFD-sham (open circle), and HFD-SE (solid circle)
pups. Results are expressed as mean 6 S.E.M. Data were analysed by ANOVA with repeated measures followed by a post hoc LSD test. Area under the
curve for (A) is shown in (B). (C) TNFa mRNA expression in the Rp fat at 12 weeks (n=12). (D) Liver phosphorylated-PKB/total PKB protein 10 min after
exogenous insulin injection (1 U/kg, ip) at 12 weeks (n=5–6) and representative blots. Results are expressed as mean 6 SEM. Data in (B), (C), and (D)
were analysed by two-way ANOVA followed by post hoc LSD tests. (A) #, P,0.05, maternal SE effect, HFD-SE & chow-SE different from HFD-sham &
chow-sham, respectively. h, P,0.05, HFD-SE different from chow-SE. (B, C) #, P,0.05, maternal SE effect; y, P,0.05, chow-sham different from the
other 3 groups. Chow-sham: offspring from dam fed chow & sham exposed; chow-SE: offspring from dam fed chow & cigarette smoke exposed; HFD-
sham: offspring from dam fed HFD & sham exposed; HFD-SE: offspring from dams fed HFD & cigarette smoke exposed.
doi:10.1371/journal.pone.0027260.g003
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insulin injection, NPY mRNA expression was significantly
downregulated in chow-sham and HFD-sham groups. The
amount of insulin that crossed the blood-brain barrier in such a
short time may have caused a small transient activation of these
components of the insulin signaling cascade, but the changes in
neurotransmitter expression indicate a stimulation of the hypo-
thalamus with the hormone. The diminished response of NPY to
insulin in offspring from both groups of SE dams suggests maternal
SE led to an impairment of hypothalamic insulin action. Loss of
hypothalamic insulin signaling is sufficient to induce obesity and
peripheral insulin resistance [66,67]. Hypothalamic insulin action
is an important contributor to the suppression of hepatic glucose
production (24). The offspring of SE mothers showed significant
glucose intolerance, which may be an early manifestation of
impaired brain insulin signaling that could lead to a profound
insulin resistance and type 2 diabetes later in life. Further long-
term studies are required to determine the exact degree of
deterioration of brain insulin signaling and its consequences on
peripheral glucose homeostasis. However this may not be the only
Figure 4. mRNA and protein expression in the hypothalamus. mRNA expression of NPY (A), Y1 receptor (B), POMC (C), and Sim1 (D), and
phosphorylated/total GSK protein (E) and phosphorylated-PKB protein (F) before and 10 min after exogenous insulin injection (1 U/kg, ip) in the
offspring hypothalamus at 12 weeks (n=8–9). Results are expressed as mean 6 SEM. Data in (A) and (C) were analysed by multiple-factor ANOVA
followed by post hoc LSD tests. Data in (B) and (D) were analysed by two-way ANOVA followed by post hoc LSD tests. *, P,0.05, maternal HFD effect;
**, P,0.05, significantly different from chow-SE group; g,P ,0.05, insulin injection effect. (A) saline injection (open bars), insulin injection (1 U/kg,
closed bars). Chow-sham: offspring from dam fed chow & sham exposed; chow-SE: offspring from dam fed chow & cigarette smoke exposed; HFD-
sham: offspring from dam fed HFD & sham exposed; HFD-SE: offspring from dams fed HFD & cigarette smoke exposed. NPY: neuropeptide Y; POMC:
proopiomelanocortin; Sim1: single-minded gene 1.
doi:10.1371/journal.pone.0027260.g004
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SE mothers. The phosphorylation of PKB in the liver is a crucial
step leading to both suppression of hepatic glucose production and
glucose uptake, and would be expected to occur after administra-
tion of exogenous insulin. Maternal exposure to smoke combined
with HFD was sufficient to impair liver insulin action, as evidenced
by a tendency to reduced phosphorylated/total PKB in insulin
stimulated HFD-SE mice. Although the reduction did not reach
statistical significance, it is likely that if animals are exposed to
HFD after weaning such defects would be amplified and the liver
would be the first tissue to show insulin resistance as seen in
intrauterine growth retardation [68]. This suggests that changes in
the liver may be contributing to the propensity to diabetes created
by intrauterine SE [69].
The brain can sense the increase in blood glucose levels to
inhibit liver glucose production. This regulation requires the
glucose to be converted into lactate followed by stimulation of
pyruvate metabolism [70]. Reduced capacity of brain glucose-
lactate-pyruvate conversion and transport between astrocytes and
neurons has been shown to diminish the negative feedback of
gluconeogenesis leading to rising blood glucose level [70]. MCTs
are involved in the transport of lactate and pyruvate between cells
[71]. MCT4 and MCT2 are the predominant isoforms in
astrocytes and neurons respectively [72]. Astrocytic MCT4 exports
lactate produced during glycolysis into the extracellular space,
from where MCT2 transports it into postsynaptic dendrites for
mitochondrial oxidation [72]. In this study, MCT2 and MCT4
were reduced by both maternal HFD and SE, which may reduce
the process of glucose-lactate-pyruvate metabolism, suggesting
brain glucose metabolism is very sensitive to any adverse
intrauterine nutritional change. This can further contribute to
the glucose intolerance observed in these offspring.
In addition to nicotine, other products of cigarette smoke, such
as carbon monoxide, can also directly affect the fetal brain [14].
Maternal nicotine exposure has been shown to reduce hypotha-
lamic NPY and increase POMC expression in newborns [25]. The
current study reveals that in the long term, hypothalamic NPY was
Figure 5. mRNA expression of MCTs in the hypothalamus.
mRNA expression of MCT2 (A), and MCT4 (B) in the offspring
hypothalamus at 12 weeks (n=8–9). Results are expressed as mean 6
SEM. Data were analysed by two-way ANOVA followed by a post hoc
LSD tests. *, P,0.05, maternal HFD effect; y, P,0.05, significantly
different from all the other 3 groups. Chow-sham: offspring from dam
fed chow & sham exposed; chow-SE: offspring from dam fed chow &
cigarette smoke exposed; HFD-sham: offspring from dam fed HFD &
sham exposed; HFD-SE: offspring from dams fed HFD & cigarette smoke
exposed.
doi:10.1371/journal.pone.0027260.g005
Figure 6. mRNA expression of CPT-1 a and ATGL in the fat.
mRNA expression of CPT-1a (A), and ATGL (B) in the Rp fat at 12 weeks
(n=8–9). Results are expressed as mean 6 SEM. Data were analysed by
two-way ANOVA followed by post hoc LSD tests. *, P,0.05, maternal
HFD effect; #,P ,0.05, maternal SE effect; y, P,0.05, significantly
different from the other 3 groups. Chow-sham: offspring from dam fed
chow & sham exposed; chow-SE: offspring from dam fed chow &
cigarette smoke exposed; HFD-sham: offspring from dam fed HFD &
sham exposed; HFD-SE: offspring from dams fed HFD & cigarette smoke
exposed.
doi:10.1371/journal.pone.0027260.g006
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maternal SE; however, Y1 receptor mRNA was significantly
reduced by both maternal HFD consumption and SE. NPY
activates several seven-transmembrane-domain G-protein-coupled
receptors. The feeding stimulatory effect of NPY is primarily
mediated through Y1 and Y5 receptors. Blockade of the Y1
receptor can eliminate the bulk of NPY-induced and fasting-
induced feeding [73,74,75]. The reduced energy intake in chow-
SE, HFD-sham and HFD-SE was mirrored by the downregulation
in Y1 mRNA. Therefore, the Y1 receptor changes may directly
contribute to reduced energy intake, even when NPY production
was unchanged, such as in the SE-chow group. The Y5 receptor
has been postulated to maintain the feeding response rather than
initiate feeding in response to NPY [76]. On the other hand
presynaptic Y2 receptors inhibit NPY release from the hypothal-
amus negatively regulating NPY [77]. Any additional contribution
of these two receptors would require further investigation.
Adipose tissue derived leptin directly accesses the hypothalamus,
reducing NPY and activating POMC to inhibit feeding and
increase energy expenditure. In the current study, leptin was
significantly increased in offspring from SE dams only, which was
mainly due to increased production in white fat. Both smoking in
humans and nicotine infusion in rodents increased plasma leptin
concentration, as well as leptin mRNA expression in fat [78,79].
Elevated plasma leptin remains after smoke cessation [78]. The
increased plasma leptin and mRNA expression in chow-SE mice
independent of fat mass could be directly due to intrauterine SE.
This is offset by additional maternal HFD consumption in the
HFD-SE group which requires further investigation. It seems that
increased leptin level was only linked to increased hypothalamic
expression of Sim1, lying downstream of POMC derived a-
melanocyte-stimulating hormone, in the chow-SE group. Howev-
er, here altered Sim1 was not link to any change in energy intake
or body weight. The exact role of increased leptin secretion
requires further investigation. Human studies suggest that
maternal smoking can lead to increased immobility in offspring
[29,80], which could lead to significantly reduced energy
expenditure. This may help to explain the discrepancy between
reduced energy intake and adiposity observed in our study.
In summary, maternal cigarette SE and HFD consumption
prior to, and during gestation and lactation led to faster growth
during the suckling period and increased adiposity in adulthood in
female offspring. Both exposures also caused disordered brain
lactate transport. However, maternal SE played a stronger role in
impairing glucose tolerance and brain insulin action. These
findings offer a potential target for future interventions to reverse
the detrimental maternal impact. Smoking cessation during
pregnancy remains desirable to improve health outcomes in
offspring.
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